Pherecydes published the long-awaited results of PhagoBurn, the first blinded, controlled, randomized phage trial on burn patients.
Steffanie Strathdee and Urmi S. Bajpai announced a new 12-month postdoc position starting July 2019. The postdoc will work on phages in Dr. Bajpai’s lab at ANDC in Delhi. Contact [email protected] to apply (fellowship application deadline is November 15, 2018).
No new jobs this week. If you’d like to add one, please post one by emailing [email protected]
Have a question or request for the phage community? Post it here and reach > 200 phage enthusiasts spanning academia, industry, medicine, and beyond. Feel free to be creative about what you might ask! (e.g. collaborations, advice, seeking opportunities)
The community board is empty this week. Be the first to post something for next week!
Phage therapy has been around for almost a century, but has had its various starts and stops. The attempts to use phages to battle against bacterial infections were more or less halted when antibiotics became a thing in the 40’s.
One of these people was Tom Patterson, who suffered a case from antibiotic-resistant Acinetobacter baumanii, which he caught from a vacation trip to Egypt. Luckily for him, his wife is the associate dean of global health sciences, and an unstoppable force of nature, and was able to save his life by gathering a crack team of doctors and researchers in the nick of time.
Watch her describe her efforts in her TedX talk:
Next issue, we’ll cover phage clinical trials—what’s been done, what was learned, and what’s in the works.
Thanks for reading!
~ Jan and Jessica
For every issue of Capsid & Tail, we are committed to getting our facts straight, but we’re not experts in the information we’re bringing to you. If you feel that we’ve missed an important viewpoint, or if you have something to add, please reach out to us by emailing [email protected]. We’d love to hear from you, and we’d be happy to revisit topics we’ve covered (ideally with added information and viewpoints from community members like you!).
Lastly, please reach out if you’re interested in writing for us, or have suggestions for future issues!